Reminder: The pictures displayed on this site maybe different from the actual appearance of the product,their maybe a delay in updating the recent picture if their a newly launched packaging from the manufacturer
ROZLYTREK
Rozlytrek is a prescription drug used to treat the symptoms of Non-small Cell Lung Cancer and Solid Tumors with the Neurotrophic Tyrosine Receptor Kinase Gene Fusion. Rozlytrek can be taken on its own or in combination with other drugs. Rozlytrek is a Tyrosine Kinase Inhibitor that belongs to the An
Trade name
ROZLYTREK
Manufacturer
Roche
Main ingreadient
Entrectinib
Specification
200mg*90 Capsules
Logistics
Please negotiate the logistics method with customer service, customer service Whatsapp/Wechat
Reminder
Please follow the doctor’s advice when taking medicines. The mall only guarantees the quality of the medicines and does not provide medical advice.
With the Neurotrophic Tyrosine Receptor Kinase Gene Fusion, Rozlytrek is a prescription medicine used to treat the symptoms of Non-small Cell Lung Cancer and Solid Tumors. Rozlytrek can be taken on its own or in combination with other drugs.
Rozlytrek is a Tyrosine Kinase Inhibitor that belongs to the Antineoplastics class of medicines.
Rozlytrek is not known to be safe or effective in children under 12.
Adults should take 600 mg of ROZLYTREK once a day, with or without food, until illness progression or unacceptable toxicity occurs.